Open Access · CC BY 4.0
Is gadolinium use still justified in MRI? Predicting enhancement to guide contrast use in neuro-oncology
The Lancet Medical Imaging & Theranostics · 2026
DOI: 10.1016/j.lanmit.2026.100023 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Lancet Medical Imaging & Theranostics, 2026. Verfasst von Felix Tobias Kurz. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kurz, F. T. (2026). Is gadolinium use still justified in MRI? Predicting enhancement to guide contrast use in neuro-oncology. The Lancet Medical Imaging & Theranostics. https://doi.org/10.1016/j.lanmit.2026.100023
Vancouver
Kurz FT. Is gadolinium use still justified in MRI? Predicting enhancement to guide contrast use in neuro-oncology. The Lancet Medical Imaging & Theranostics. 2026. doi:10.1016/j.lanmit.2026.100023
BibTeX
@article{Kurz2026,
author = {Kurz, Felix Tobias},
title = {Is gadolinium use still justified in MRI? Predicting enhancement to guide contrast use in neuro-oncology},
journal = {The Lancet Medical Imaging & Theranostics},
year = {2026},
doi = {10.1016/j.lanmit.2026.100023}
}
EUVIMED